Portal de Periódicos da CAPES

Somatic Evolution in Non-Neoplastic IBD-Affected Colon

2020; RELX Group (Netherlands); Linguagem: Inglês

10.2139/ssrn.3554074

1556-5068

Sigurgeir Ólafsson, Rebecca E. McIntyre, Tim H. H. Coorens, Timothy Butler, Hyunchul Jung, Philip S. Robinson, Henry Lee-Six, Mathijs A. Sanders, Kenneth Arestang, Claire Dawson, Monika Tripathi, Konstantina Strongili, Yvette Hooks, Michael R. Stratton, Miles Parkes, Iñigo Martincorena, Tim Raine, Peter J. Campbell, Carl A. Anderson,

RNA and protein synthesis mechanisms

Inflammatory bowel disease (IBD) is a chronic inflammatory disease associated with increased risk of gastrointestinal cancers. Here, we whole-genome sequenced 447 colonic crypts from 46 IBD patients, and compared these to 412 crypts from 41 non-IBD controls. The average mutation rate of affected colonic epithelial cells is 2.4-fold that of healthy colon and this increase is mostly driven by acceleration of mutational processes ubiquitously observed in normal colon. In contrast to the normal colon, where clonal expansions outside the confines of the crypt are rare, we observed widespread millimeter-scale clonal expansions. We discovered non-synonymous mutations in ARID1A, FBXW7, PIGR and ZC3H12A, and genes in the interleukin 17 and Toll-like receptor pathways, under positive selection in IBD. These results suggest distinct selection mechanisms in the colitis-affected colon and that somatic mutations potentially play a causal role in IBD pathogenesis.